(Q33837599)

29 July 2017

title

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans (English)

1 reference

29 July 2017

0 references

6

Marian W Fischman

1 reference

29 July 2017

1

Sandra D Comer

1 reference

29 July 2017

Eric D Collins

2

1 reference

29 July 2017

Herbert D Kleber

series ordinal

3

1 reference

29 July 2017

Elie S Nuwayser

series ordinal

4

1 reference

29 July 2017

James H Kerrigan

series ordinal

5

1 reference

29 July 2017

language of work or name

1 reference

1 November 2001

1 reference

29 July 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

29 July 2017

volume

159

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

351-360

1 reference

https://scigraph.springernature.com/pub.10.1007/s002130100909

29 July 2017

exact match

0 references

cites work

Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Adverse effects of oral naltrexone: analysis of data from two clinical trials

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Aversive effects of naltrexone in subjects not dependent on opiates

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

A sustained release depot for narcotic antagonists.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Clinical evaluation of a naltrexone sustained-release preparation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Implantable narcotic antagonists: a possible new treatment for narcotic addiction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Naltrexone: lack of effect on hepatic enzymes.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Naltrexone-induced dysphoria in former opioid addicts

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Nontolerance to the opioid antagonism of naltrexone

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Duration of occupancy of opiate receptors by naltrexone

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Naltrexone treatment--the problem of patient acceptance

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Clinical Experience with Naltrexone

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Psychopathology, craving, and mood during heroin acquisition: an experimental study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Opiate Antagonists and the Modification of Heroin Self-Administration Behavior in Man: An Experimental Study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Improvement in naltrexone treatment compliance with contingency management.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Lack of hepatotoxicity with naltrexone treatment

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Operant analysis of human heroin self-administration and the effects of naltrexone.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

High-Dose Naltrexone and Liver Function Safety

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Two New Rating Scales for Opiate Withdrawal

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079470

Sustained-release naltrexone for alcoholism treatment: a preliminary study

29 October 2018

1 reference

12 December 2020

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

12 December 2020

Biocompatible implants for the sustained zero-order release of narcotic antagonists

1 reference

12 December 2020

Effects of smoking on rapid information processing performance

1 reference

12 December 2020

Rating the presence and severity of opiate dependence

1 reference

12 December 2020

Strategies to Improve Compliance with Narcotic Antagonists

1 reference

12 December 2020

An experimental study in the treatment of narcotic addicts with cyclazocine

1 reference

12 December 2020

Craving in heroin addicts maintained on the opiate antagonist naltrexone

1 reference

12 December 2020

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

12 December 2020

Naltrexone treatment of opiate-dependent persons

1 reference

12 December 2020

Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry

1 reference

12 December 2020

Behavioral and subjective effects of DN-2327 (pazinaclone) and alprazolam in normal volunteers

1 reference

12 December 2020

Naltrexone: a clinical perspective

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002130100909

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference